|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:BlackThorn_Therapeutics
|
|
gptkbp:CEO
|
gptkb:Paul_L._Berns
|
|
gptkbp:focusesOn
|
neuroscience
central nervous system disorders
|
|
gptkbp:foundedYear
|
2019
|
|
gptkbp:founder
|
gptkb:Carolyn_Bertozzi
gptkb:Vikram_Bajaj
gptkb:Jeffrey_Jonas
gptkb:Srinivas_Akkaraju
gptkb:Paul_L._Berns
gptkb:Charles_Homcy
|
|
gptkbp:headquartersLocation
|
gptkb:Watertown,_Massachusetts,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Neumora Therapeutics
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:mission
|
to redefine neuroscience drug development
|
|
gptkbp:notableInvestment
|
gptkb:Arch_Venture_Partners
gptkb:SoftBank_Vision_Fund_2
gptkb:Amgen
gptkb:Fidelity_Management_&_Research_Company
|
|
gptkbp:notableProduct
|
gptkb:NMRA-140
gptkb:NMRA-511
|
|
gptkbp:pipelineFocus
|
gptkb:depression
neuropsychiatric disorders
anxiety disorders
|
|
gptkbp:publiclyTraded
|
yes
|
|
gptkbp:stockExchange
|
gptkb:NASDAQ
|
|
gptkbp:stockSymbol
|
gptkb:NMRA
|
|
gptkbp:technology
|
data science
precision neuroscience
|
|
gptkbp:website
|
https://www.neumoratx.com/
|
|
gptkbp:bfsParent
|
gptkb:Third_Rock_Ventures
|
|
gptkbp:bfsLayer
|
6
|